96193 ⎘
Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds; Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms Six-membered rings
Sub-classes:MORPHOLINE-BASED ORGANOPHOSPHINE LIGAND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#2NOVEL THIOL REDUCTANT, METHOD AND USE THEREOF
#3COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TRANSTHYRETIN
#4METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND
#5Compositions and methods for inhibiting expression of transthyretin
#6Phosphorodiamidate morpholino oligomers
#7METHOD FOR PRODUCING SOLID ELECTROLYTE
#8ANTISENSE-INDUCED EXON2 INCLUSION IN ACID ALPHA-GLUCOSIDASE
#9RNA INTERFERENCE COMPOSITIONS AND METHODS FOR MALIGNANT TUMORS
#10Metal-chelating compositions and their use in methods of removing or inhibiting barium scale
#11Synthesis of Fmoc-protected morpholino monomers and their use in the synthesis of morpholino oligomer
#12Phosphonamidates that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer
#13PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS
#14Compositions and Methods for Inhibiting Expression of Transthyretin
#15Sulfur derivatives as chemokine receptor modulators
#16PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS
#17Morpholino oligonucleotide manufacturing method
#18Phosphonamidates that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer
#19Processes for preparing phosphorodiamidate morpholino oligomers
#20Method for the synthesis of alpha-aminoalkylenephosphonic acid
#21STAT6 inhibitors
#22Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins
#23RNA interference agents for p21 gene modulation
#24Morpholino oligonucleotide manufacturing method
#25PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS
#26Selective caspase inhibitors and uses thereof
#27Sulfur derivatives as chemokine receptor modulators
#28Biocompatible flavonoid compounds for organelle and cell imaging
#29RNA interference agents for GST-PI gene modulation
#30Antisense-induced exon2 inclusion in acid alpha-glucosidase
#31RNA interference agents for P21 gene modulation
#32RNA agents for P21 gene modulation
#33RNA agents for GST-Pi gene modulation
#34RNA interference compositions and methods for malignant tumors
#35Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins
#36STAT6 inhibitors
#37Sulfur derivatives as chemokine receptor modulators
#38(Thio)morpholine derivatives as S1P modulators
#39METHOD FOR THE SYNTHESIS OF ALPHA-AMINOALKYLENEPHOSPHONIC ACID
#40PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS
#41Method for the synthesis of aminoalkylenephosphonic acid
#42ANTISENSE-INDUCED EXON2 INCLUSION IN ACID ALPHA-GLUCOSIDASE
#43Method for stabilizing LiPF, electrolyte solution for nonaqueous secondary batteries having excellent thermal stability, and nonaqueous secondary battery having excellent thermal stability
#44Selective caspase inhibitors and uses thereof
#45NOVEL UREA AND THIOUREA DERIVATIVES
#46Composition for preventing and treating non-small cell lung cancer, containing pyrazino-triazine derivatives
#47Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins
#48Sulfur derivatives as chemokine receptor modulators
#49Sulfur derivatives as chemokine receptor modulators
#50Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins
#51Morpholino-based antisense agent
#52Compositions and methods for inhibiting expression of transthyretin
#53(Thio)morpholine derivatives as S1P modulators
#54Phosphoramide compound, method for producing the same, ligand, complex, catalyst and method for producing optically active alcohol
#55Phosphorous derivatives as kinase inhibitors
#56Sulfur derivatives as chemokine receptor modulators
#57Phosphorous derivatives as chemokine receptor modulators
#58Phosphonate fluorescent dyes and conjugates
#59Urea and thiourea derivatives
#60Selective caspase inhibitors and uses thereof
#61Phosphonate fluorescent dyes and conjugates
#62Compositions and methods for inhibiting expression of transthyretin
#63Phosphoramide compound, method for producing the same, ligand, complex, catalyst and method for producing optically active alcohol
#64Unnatural amino acids capable of covalently modifying protein phosphatases and their use as general and specific inhibitors and probes
#65Electrostatic-image-developing toner, method of producing the same, electrostatic image developer, image forming method and image forming apparatus
#66Pesticidal heterocycles
#67Lysine based compounds
#68PHOSPHONYLATED FLUORESCENT DYES AND CONJUGATES
#69Materials and methods to potentiate cancer treatment
#70Sulfonylethyl phosphorodiamidates
#71Phosphonate fluorescent dyes and conjugates
#721,1-and 1,2-Bisphosphonates as apoliprotein e modulators
#73Phosphonylated fluorescent dyes and conjugates
#74Compositions comprising oxophosphonate-based metalloproteinase inhibitors
#75Antineoplastic ether lipid compounds
#76Phosphonamide and phosphonamide blend compositions to treat water
#77Antiprotozoal ring-substituted phospholipids
#78Ethynyl derivatives as factor Xa inhibitors
#79Carboxamide derivatives and their use as factor Xa inhibitors
#80Noncardiotoxic pharmaceutical compounds
#81Lysine based compounds
#82Sulfonylethyl phosphorodiamidates
#83Pesticidal heterocycles
#84Method of treating a condition by administering a prostaglandin derivative
#852-decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
#86Il-6 production inhibitors
#87Phosphonamide and phosphonamide blend compositions and method to treat water
#88Process for reacting alkaloids and use of the reaction products in the preparation of medicaments